Abstract
Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.cmi.2021.11.019
Copy DOIJournal: Clinical Microbiology and Infection | Publication Date: Nov 24, 2021 |
Citations: 22 | License type: NO-CC CODE |
Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
Join us for a 30 min session where you can share your feedback and ask us any queries you have